PAD Profile : Warfarin sodium - Atrial fibrillation

PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Warfarin sodium - Atrial fibrillation

PAD Profile : Warfarin sodium - Atrial fibrillation

Keywords :

SPAF, stroke prevention in AF, anticoagulation, vitamin K antagonist, anticoagulant cards, anticoagulant alert cards,mdCalc, Cockcroft-Gault, creatinine clearance, bleed, risk, ORBIT

Traffic Light Status

Status 1 of 1.

Status :

Green

Formulations :

Tablets

Trust Alignment :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

BNF NICE SPC

NFD1

NICE

Comments :

No comments returned.

Documents :

Guidelines

The following guidelines are available for this indication.

Guidelines : Atrial fibrillation

Other Drugs

Other Indications

No indications returned.

Additional Documents

Type

Document

Review Date

Guidelines (Local)

Anticoagulation Monitoring - Primary Care service Guidelines - Jan 2018

01 January 2021

Guidelines (Local)

Atrial Fibrillation Management - Secondary Care Pathway - February 2018

01 September 2020

Guidelines (Local)

Atrial Fibrillation Management -Primary Care Pathway - February 2018

01 September 2020

Guidelines (Local)

Dual antiplatelet-anticoagulant therapy - Aide memoire for managing Hospital Requests

01 July 2023

Guidelines (Local)

Oral Anticoagulant selection tool in Atrial Fibrillation - Jun 24.pdf

30 June 2027

Guidelines (National)

NICE Clinical guideline [CG180] : Atrial fibrillation: management

Evidence Review

Atrial Fibrillation Management - Evidence Review - September 2014

Patient resource

Atrial Fibrillation - NICE Patient Decision Aid - Jun 2014

Patient resource

Starting Anticoagulation video for patients - Wessex AHSN

Information

Calculating Creatinine Clearance for DOACs - April 2020

01 April 2023

Information

Contraindications to Anticoagulants and Antiplatelets - NHS Surrey Guidance Jul11

Information

ORBIT Bleed risk scoring tool for anticoagulation in AF - March 2022.pdf

01 January 2025

Committee Recommendations

Date

Committee Name

Narrative

07 February 2024

Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed the updated Surrey Heartlands Oral Anticoagulant selection tool in Atrial Fibrillation.

Apixaban is now the recommended 1st-line DOAC in accordance with the updated NHSE Commissioning Recommendations.

Apixaban is available generically and is the most cost-effective DOAC.

Refer to the Oral Anticoagulation Selection Tool for full guidance.

02 March 2022

Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands ICS Area Prescribing Committee have agreed the use of an ORBIT-bleed risk scoring tool when considering or reviewing anticoagulant treatment in Atrial Fibrillation (AF).

01 June 2016

Surrey Medicines Commissioners Group

Surrey Medicines Commissioning Group recommend that patients prescribed all types of anticoagulants (warfarin and NOACs) should be given an anticoagulant alert card to carry with them. For patients taking NOACs, the card should be annotated on the reverse in the “Therapeutic range (INR)” box with the words “not applicable” or “not required for this drug”. The cards are available for practices to order through usual NHS stationery supply routes. See an example of the Anticoagulant Alert Card in the document below

04 March 2020

Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The Surrey & North West Sussex Area Prescribing Committee have agreed the updated guidance on calculating creatinine clearance for DOACs.

Associated BNF Codes

02. Cardiovascular System

02.08.02. Oral anticoagulants